logoTry Persana

BillionToOne - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about BillionToOne including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

BillionToOne company logo

We push the boundaries of molecular diagnostics through quantitative technologies.

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible.

HeadquartersMenlo Park, United States
Team size500-1000
Founded2016

What is BillionToOne? - Company Overview & Details

BillionToOne is BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Founded in 2016, the company is headquartered in Menlo Park, United States.

Who Founded BillionToOne?

BillionToOne was founded by Oguzhan Atay, David Tsao.

Who are the Key Executives at BillionToOne? - Leadership Team

BillionToOne is led by experienced executives in key positions:

Chief Executive Officer (CEO) of BillionToOne

Oguzhan AtayCEO

Chief Technology Officer (CTO) of BillionToOne

CTO

About Oguzhan Atay - CEO of BillionToOne

Oguzhan Atay serves as the Chief Executive Officer of BillionToOne, leading the company's strategic vision and operations.

BillionToOne Company Details & Key Information

Where is BillionToOne located?

BillionToOne is headquartered in Menlo Park, United States.

How many employees does BillionToOne have?

BillionToOne has 500-1000 employees.

When was BillionToOne founded?

BillionToOne was founded in 2016.

BillionToOne Official Website

How much funding has BillionToOne raised?

BillionToOne has raised $130 Million across 8 funding rounds. The most recent funding was completed on 2024-07-21.

Funding Overview

BillionToOne has raised a total of $130 million in its latest Series D funding round, led by Premji Invest.

$130 Million
Total Funding Raised
8
Funding Rounds
2024-07-21
Latest Round

BillionToOne Funding History

Series D
2024-07-21
$130 Million

Who are the key investors in BillionToOne?

BillionToOne is backed by 7 key investors including Premji Invest, Neuberger Berman, Adam Street Partners. These investors focus on sectors.

BillionToOne Investor Overview

7
Key Investors
0
Focus Areas
0
Notable Investments

Complete List of BillionToOne Investors

Premji Invest

Neuberger Berman

Adam Street Partners

Baillie Gifford

Hummingbird Ventures

Civilization Ventures

Fifty Years

What sectors do BillionToOne investors focus on?

The investors backing BillionToOne primarily focus on sectors.

Featured Investor: Premji Invest

Premji Invest

Notable Investments:

What are BillionToOne's future plans?

BillionToOne Continue expanding products in prenatal and oncology diagnostics.

BillionToOne Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does BillionToOne face?

BillionToOne has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for BillionToOne

1

Regulatory hurdles

2

Market competition

What opportunities does BillionToOne have?

BillionToOne has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for BillionToOne

1

Growth in prenatal testing market

2

Expanding oncology liquid biopsy capabilities

BillionToOne Strategic Position Summary

Key Focus Areas

BillionToOne is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about BillionToOne?

BillionToOne has 2 recent news updates covering key business developments and market activities.

BillionToOne News Overview

2
Recent Articles
Active
Media Coverage
2025-05-16
Latest Update

What is BillionToOne in the news for?

BillionToOne is currently featured in news for BillionToOne, Inc. launches expanded version of UNITY Fetal Risk Screen. and other significant business developments.

Recent News Articles About BillionToOne

Article 1
2025-05-16

BillionToOne, Inc. launches expanded version of UNITY Fetal Risk Screen.

BillionToOne expands prenatal test to screen for 14 genetic conditions from a single maternal blood sample.

femtechinsider.com
Read News
Article 2
2025-05-15

BillionToOne, Inc. hired Haywood L. Brown as Chief Medical Officer, Prenatal on May 15th '25.

BillionToOne expands executive team with Dr. Haywood Brown as Chief Medical Officer, Prenatal.

billiontoone.com
Read News

BillionToOne FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about BillionToOne including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

BillionToOne Questions & Answers - Company Information

Q1

What is BillionToOne?

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible.

Q2

Who founded BillionToOne?

BillionToOne was founded by Oguzhan Atay, David Tsao.

Q3

Who is the CEO of BillionToOne?

The CEO of BillionToOne is Oguzhan Atay.

Q4

How much funding has BillionToOne raised?

BillionToOne has raised a total of $$130 Million across 8 funding rounds. The most recent funding was completed on 2024-07-21.

Q5

Who are the investors in BillionToOne?

BillionToOne's key investors include Premji Invest, Neuberger Berman, Adam Street Partners, Baillie Gifford, Hummingbird Ventures, Civilization Ventures, Fifty Years.

Q6

Where is BillionToOne headquartered?

BillionToOne is headquartered in Menlo Park, United States.

Q7

When was BillionToOne founded?

BillionToOne was founded in 2016.

Q8

How many employees does BillionToOne have?

BillionToOne has 500-1000 employees.

Q9

What is BillionToOne's official website?

You can visit BillionToOne's official website at https://www.billiontoone.com.

Q10

What was BillionToOne's latest funding round?

BillionToOne's latest funding round was a Series D round of $$130 Million completed on 2024-07-21.

Q11

Who is founder?

Oguzhan Atay

Q12

What does the company do?

BillionToOne develops precision diagnostics, particularly for prenatal and oncology testing.

Q13

How much funding?

$130 Million

Q14

Latest funding date?

2024-07-21

Q15

Who are the investors?

Premji Invest Neuberger Berman Adam Street Partners Baillie Gifford Hummingbird Ventures Civilization Ventures Fifty Years

Q16

What are the challenges?

Regulatory hurdles Market competition

Q17

What are the opportunities?

Growth in prenatal testing market Expanding oncology liquid biopsy capabilities

Q18

Latest news?

BillionToOne expands prenatal test to screen for 14 genetic conditions from a single maternal blood sample. BillionToOne expands executive team with Dr. Haywood Brown as Chief Medical Officer, Prenatal.

More Information About BillionToOne

For additional details about BillionToOne, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.